表紙
市場調查報告書

病毒惰性化的全球市場

Viral Inactivation

出版商 Global Industry Analysts, Inc. 商品編碼 909458
出版日期 內容資訊 英文 143 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
病毒惰性化的全球市場 Viral Inactivation
出版日期: 2019年10月01日內容資訊: 英文 143 Pages
簡介

本報告提供全球病毒惰性化市場調查,提供市場概要,各產品(套件·試劑,系統,服務),用途(疫苗·治療藥,幹細胞產品,血液·血液製劑),組織·組織產品,細胞治療·基因治療),地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭情形

  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CLEAN CELLS INC.
  • DANAHER CORPORATION
  • MERCK KGAA
  • PARKER HANNIFIN CORPORATION
  • RAD SOURCE TECHNOLOGIES, INC.
  • SGS GROUP (SGS SA)
  • SARTORIUS AG
  • TEXCELL, INC.
  • V.I.P.S. SA
  • WUXI APPTEC

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP15506

Viral Inactivation market worldwide is projected to grow by US$496.2 Million, driven by a compounded growth of 12.4%. Kits & Reagents, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$513.3 Million by the year 2025, Kits & Reagents will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 13.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$19.9 Million to the region's size and clout in the next 5 to 6 years. Over US$23.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Kits & Reagents will reach a market size of US$38.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 12.3% over the next couple of years and add approximately US$88.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Charles River Laboratories International, Inc.; Clean Cells Inc.; Danaher Corporation; Merck KgaA; Parker Hannifin Corporation; Rad Source Technologies, Inc.; Sartorius AG; SGS Group (SGS SA); Texcell, Inc.; V.I.P.S. SA; WuXi AppTec Group

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Viral Inactivation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Viral Inactivation Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Viral Inactivation Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Viral Inactivation Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Kits & Reagents (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Kits & Reagents (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Kits & Reagents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Systems (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Systems (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: Systems (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Services (Product) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 11: Services (Product) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 12: Services (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Vaccines and Therapeutics (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025
  • TABLE 14: Vaccines and Therapeutics (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017
  • TABLE 15: Vaccines and Therapeutics (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Stem Cell Products (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 17: Stem Cell Products (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017
  • TABLE 18: Stem Cell Products (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Blood and Blood Products (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025
  • TABLE 20: Blood and Blood Products (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017
  • TABLE 21: Blood and Blood Products (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
  • TABLE 22: Tissue/ Tissue Products (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025
  • TABLE 23: Tissue/ Tissue Products (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017
  • TABLE 24: Tissue/ Tissue Products (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Cellular and Gene Therapy (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
  • TABLE 26: Cellular and Gene Therapy (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017
  • TABLE 27: Cellular and Gene Therapy (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Viral Inactivation Market Share (in %) by Company: 2019 & 2025
    • TABLE 28: United States Viral Inactivation Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025
    • TABLE 29: Viral Inactivation Market in the United States by Product: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 30: United States Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 31: United States Viral Inactivation Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025
    • TABLE 32: Viral Inactivation Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017
    • TABLE 33: Viral Inactivation Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 34: Canadian Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025
    • TABLE 35: Canadian Viral Inactivation Historic Market Review by Product in US$ Thousand: 2009-2017
    • TABLE 36: Viral Inactivation Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 37: Canadian Viral Inactivation Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 38: Viral Inactivation Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017
    • TABLE 39: Canadian Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 40: Japanese Market for Viral Inactivation: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025
    • TABLE 41: Viral Inactivation Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017
    • TABLE 42: Japanese Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 43: Japanese Demand Estimates and Forecasts for Viral Inactivation in US$ Thousand by Application: 2018 to 2025
    • TABLE 44: Japanese Viral Inactivation Market in US$ Thousand by Application: 2009-2017
    • TABLE 45: Viral Inactivation Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 46: Chinese Viral Inactivation Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025
    • TABLE 47: Viral Inactivation Historic Market Analysis in China in US$ Thousand by Product: 2009-2017
    • TABLE 48: Chinese Viral Inactivation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 49: Chinese Demand for Viral Inactivation in US$ Thousand by Application: 2018 to 2025
    • TABLE 50: Viral Inactivation Market Review in China in US$ Thousand by Application: 2009-2017
    • TABLE 51: Chinese Viral Inactivation Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Viral Inactivation Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 52: European Viral Inactivation Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 53: Viral Inactivation Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 54: European Viral Inactivation Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 55: European Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025
    • TABLE 56: Viral Inactivation Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017
    • TABLE 57: European Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 58: European Viral Inactivation Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 59: Viral Inactivation Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017
    • TABLE 60: European Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 61: Viral Inactivation Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 62: French Viral Inactivation Historic Market Scenario in US$ Thousand by Product: 2009-2017
    • TABLE 63: French Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 64: Viral Inactivation Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025
    • TABLE 65: French Viral Inactivation Historic Market Review in US$ Thousand by Application: 2009-2017
    • TABLE 66: French Viral Inactivation Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • GERMANY
    • TABLE 67: Viral Inactivation Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025
    • TABLE 68: German Viral Inactivation Historic Market Analysis in US$ Thousand by Product: 2009-2017
    • TABLE 69: German Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 70: Viral Inactivation Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025
    • TABLE 71: German Viral Inactivation Market in Retrospect in US$ Thousand by Application: 2009-2017
    • TABLE 72: Viral Inactivation Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 73: Italian Viral Inactivation Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025
    • TABLE 74: Viral Inactivation Historic Market Analysis in Italy in US$ Thousand by Product: 2009-2017
    • TABLE 75: Italian Viral Inactivation Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 76: Italian Demand for Viral Inactivation in US$ Thousand by Application: 2018 to 2025
    • TABLE 77: Viral Inactivation Market Review in Italy in US$ Thousand by Application: 2009-2017
    • TABLE 78: Italian Viral Inactivation Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 79: United Kingdom Market for Viral Inactivation: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025
    • TABLE 80: Viral Inactivation Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017
    • TABLE 81: United Kingdom Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 82: United Kingdom Demand Estimates and Forecasts for Viral Inactivation in US$ Thousand by Application: 2018 to 2025
    • TABLE 83: United Kingdom Viral Inactivation Market in US$ Thousand by Application: 2009-2017
    • TABLE 84: Viral Inactivation Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025
    • TABLE 86: Viral Inactivation Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017
    • TABLE 87: Rest of Europe Viral Inactivation Market Share Breakdown by Product: 2009 VS 2019 VS 2025
    • TABLE 88: Rest of Europe Viral Inactivation Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    • TABLE 89: Viral Inactivation Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017
    • TABLE 90: Rest of Europe Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 91: Viral Inactivation Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 92: Asia-Pacific Viral Inactivation Historic Market Scenario in US$ Thousand by Product: 2009-2017
    • TABLE 93: Asia-Pacific Viral Inactivation Market Share Analysis by Product: 2009 VS 2019 VS 2025
    • TABLE 94: Viral Inactivation Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025
    • TABLE 95: Asia-Pacific Viral Inactivation Historic Market Review in US$ Thousand by Application: 2009-2017
    • TABLE 96: Asia-Pacific Viral Inactivation Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • REST OF WORLD
    • TABLE 97: Rest of World Viral Inactivation Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025
    • TABLE 98: Rest of World Viral Inactivation Historic Market Review by Product in US$ Thousand: 2009-2017
    • TABLE 99: Viral Inactivation Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025
    • TABLE 100: Rest of World Viral Inactivation Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    • TABLE 101: Viral Inactivation Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017
    • TABLE 102: Rest of World Viral Inactivation Market Share Analysis by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • CLEAN CELLS INC.
  • DANAHER CORPORATION
  • MERCK KGAA
  • PARKER HANNIFIN CORPORATION
  • RAD SOURCE TECHNOLOGIES, INC.
  • SGS GROUP (SGS SA)
  • SARTORIUS AG
  • TEXCELL, INC.
  • V.I.P.S. SA
  • WUXI APPTEC

V. CURATED RESEARCH

Back to Top